Population pharmacokinetics of vancomycin and AUC-guided dosing in Chinese neonates and young infants

Objectives To develop a population pharmacokinetic (PK) model for vancomycin in Chinese neonates and infants less than 2 months of age (young infants) with a wide gestational age range, in order to determine the appropriate dosing regimen for this population.